Atea Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
Atea Pharmaceuticals, Inc. (AVIR) had Shares Outstanding (Cover Page) of 80.20 million shares as of 2026-08-10, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-10: Entity Common Stock, Shares Outstanding 80.20M shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 80.03M shares.
- 2026-03-04: Entity Common Stock, Shares Outstanding 79.67M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 78.13M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 80.20M shares 10-Q · filed 2026-08-12 |
| 2026-05-11 | 80.03M shares 10-Q · filed 2026-05-12 |
| 2026-03-04 | 79.67M shares 10-K · filed 2026-03-05 |
| 2025-11-10 | 78.13M shares 10-Q · filed 2025-11-12 |
| 2025-08-04 | 79.36M shares 10-Q · filed 2025-08-07 |
| 2025-05-09 | 85.58M shares 10-Q · filed 2025-05-12 |
| 2025-03-04 | 85.53M shares 10-K · filed 2025-03-06 |
| 2024-11-04 | 84.46M shares 10-Q · filed 2024-11-07 |
| 2024-08-07 | 84.42M shares 10-Q · filed 2024-08-07 |
| 2024-05-13 | 84.22M shares 10-Q · filed 2024-05-14 |
| 2024-02-25 | 84.16M shares 10-K · filed 2024-02-28 |
| 2023-11-07 | 83.44M shares 10-Q · filed 2023-11-08 |
| 2023-08-05 | 83.40M shares 10-Q · filed 2023-08-08 |
| 2023-05-05 | 83.40M shares 10-Q · filed 2023-05-08 |
| 2023-02-25 | 83.34M shares 10-K · filed 2023-02-28 |
| 2022-11-04 | 83.29M shares 10-Q · filed 2022-11-07 |
| 2022-08-05 | 83.26M shares 10-Q · filed 2022-08-08 |
| 2022-05-05 | 83.26M shares 10-Q · filed 2022-05-10 |
| 2022-02-25 | 83.23M shares 10-K · filed 2022-02-28 |
| 2021-11-10 | 83.10M shares 10-Q · filed 2021-11-12 |
| 2021-08-10 | 82.78M shares 10-Q · filed 2021-08-12 |
| 2021-05-13 | 82.74M shares 10-Q · filed 2021-05-13 |
| 2021-03-29 | 82.74M shares 10-K · filed 2021-03-30 |
| 2020-12-10 | 82.62M shares 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |